Skip to main content
main-content

Zeitschrift

Breast Cancer Research

Breast Cancer Research 3/2009

Sonderheft 3/2009

Controversies in Breast Cancer 2009

Inhaltsverzeichnis ( 25 Artikel )

01.12.2009 | Introduction | Sonderheft 3/2009

Controversies in Breast Cancer 2009

01.12.2009 | Section introduction | Sonderheft 3/2009

Risk factors. Introduction to Session 1

01.12.2009 | Short communication | Sonderheft 3/2009

Alcohol consumption and breast cancer risk

01.12.2009 | Short communication | Sonderheft 3/2009

Mammographic density

01.12.2009 | Short communication | Sonderheft 3/2009

Underarm antiperspirants/deodorants and breast cancer

01.12.2009 | Section introduction | Sonderheft 3/2009

Debate: tailored targeted therapy for all - a realistic and worthwhile objective? Introduction to Session 2

01.12.2009 | Short communication | Sonderheft 3/2009

Tailored targeted therapy for all: a realistic and worthwhile objective?

01.12.2009 | Short communication | Sonderheft 3/2009

Tailored targeted therapy for all: a realistic and worthwhile objective against

01.12.2009 | Section introduction | Sonderheft 3/2009

The potential of new technologies/approaches. Introduction to Sessions 3 and 4

01.12.2009 | Short communication | Sonderheft 3/2009

Clinical relevance and current challenges of research on disseminating tumor cells in cancer patients

01.12.2009 | Short communication | Sonderheft 3/2009

Gene expression profiling of breast cancer

01.12.2009 | Short communication | Sonderheft 3/2009

Next-generation sequencing

01.12.2009 | Section introduction | Sonderheft 3/2009

Who would have thought it! Influence on outcome of radiotherapy, Ki67 and stroma. Introduction to Session 5

01.12.2009 | Short communication | Sonderheft 3/2009

Radiation impact in breast cancer

01.12.2009 | Short communication | Sonderheft 3/2009

Who would have thought a single Ki67 measurement would predict long-term outcome?

01.12.2009 | Short communication | Sonderheft 3/2009

Breast tumour stroma is a prognostic indicator and target for therapy

01.12.2009 | Section introduction | Sonderheft 3/2009

Introduction to sessions on guidelines and endocrine therapy, the influence of breast screening on number of mastectomies and the challenge between molecular science and traditional dogma in the treatment of breast cancer. Introduction to Session 6

01.12.2009 | Short communication | Sonderheft 3/2009

Do BIG1-98 and ZOFAST demand a change in guidelines for endocrine therapy?

01.12.2009 | Short communication | Sonderheft 3/2009

Breast screening has increased the number of mastectomies

01.12.2009 | Section introduction | Sonderheft 3/2009

Are current drug development programmes realising the full potential of new agents? Introduction to Sessions 7 and 8

01.12.2009 | Short communication | Sonderheft 3/2009

Are current drug development programmes realising the full potential of new agents? The scenario

01.12.2009 | Short communication | Sonderheft 3/2009

The role of preclinical animal models in breast cancer drug development

01.12.2009 | Short communication | Sonderheft 3/2009

Foundation clinical trials

01.12.2009 | Short communication | Sonderheft 3/2009

Are current drug development programmes realising the full potential of new agents? Tyrosine kinase inhibitors

01.12.2009 | Short communication | Sonderheft 3/2009

Controversies in breast cancer: the mammalian target of rapamycin as a target for breast cancer therapy

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise